Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.Pediatr Infect Dis J. 2011 Feb; 30(2):180-1.PI
Abstract
Kala-azar or visceral leishmaniasis is a disseminated protozoal infection caused by parasites of the genus Leishmania (Leishmania donovani in India). Conventional therapy for visceral leishmaniasis continues to be pentavalent antimony (sodium antimony gluconate [SAG]). Amphotericin B is widely used for SAG-unresponsive cases and sometimes even as a first-line drug, especially in endemic areas. With the conventional regimen of SAG, cardiac toxicity has been reported in 8% to 17% of cases with 5% to 7% of them having fatal toxicity. Cardiac toxicity is uncommon with amphotericin B with only few isolated reports. We report some patients with kala-azar in whom coadministration of SAG and amphotericin B led to arrhythmia and sudden death.
Links
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
20823781
Citation
Maheshwari, Anu, et al. "Cumulative Cardiac Toxicity of Sodium Stibogluconate and Amphotericin B in Treatment of Kala-azar." The Pediatric Infectious Disease Journal, vol. 30, no. 2, 2011, pp. 180-1.
Maheshwari A, Seth A, Kaur S, et al. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar. Pediatr Infect Dis J. 2011;30(2):180-1.
Maheshwari, A., Seth, A., Kaur, S., Aneja, S., Rath, B., Basu, S., Patel, R., & Dutta, A. K. (2011). Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar. The Pediatric Infectious Disease Journal, 30(2), 180-1. https://doi.org/10.1097/INF.0b013e3181f55843
Maheshwari A, et al. Cumulative Cardiac Toxicity of Sodium Stibogluconate and Amphotericin B in Treatment of Kala-azar. Pediatr Infect Dis J. 2011;30(2):180-1. PubMed PMID: 20823781.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
AU - Maheshwari,Anu,
AU - Seth,Anju,
AU - Kaur,Satnam,
AU - Aneja,Satinder,
AU - Rath,Bimbadhar,
AU - Basu,Srikanta,
AU - Patel,Rakesh,
AU - Dutta,Ashok Kumar,
PY - 2010/9/9/entrez
PY - 2010/9/9/pubmed
PY - 2011/4/22/medline
SP - 180
EP - 1
JF - The Pediatric infectious disease journal
JO - Pediatr Infect Dis J
VL - 30
IS - 2
N2 - Kala-azar or visceral leishmaniasis is a disseminated protozoal infection caused by parasites of the genus Leishmania (Leishmania donovani in India). Conventional therapy for visceral leishmaniasis continues to be pentavalent antimony (sodium antimony gluconate [SAG]). Amphotericin B is widely used for SAG-unresponsive cases and sometimes even as a first-line drug, especially in endemic areas. With the conventional regimen of SAG, cardiac toxicity has been reported in 8% to 17% of cases with 5% to 7% of them having fatal toxicity. Cardiac toxicity is uncommon with amphotericin B with only few isolated reports. We report some patients with kala-azar in whom coadministration of SAG and amphotericin B led to arrhythmia and sudden death.
SN - 1532-0987
UR - https://www.unboundmedicine.com/medline/citation/20823781/Cumulative_cardiac_toxicity_of_sodium_stibogluconate_and_amphotericin_B_in_treatment_of_kala_azar_
DB - PRIME
DP - Unbound Medicine
ER -